483 Response Frontida BioPharm May 2003

Karyn Campbell FDA, Kristen Evans FDA$119.00 - Available Now

FDA investigators audited the Frontida BioPharm - Philadelphia, PA, United States facility and issued inspectional observation (via FDA 483) on 29 May 2003.

Product details

  • Category:
  • Inspection end: 29 May 2003
  • Location: Philadelphia, United States
  • FEI: 2523348
Add To Cart